Compare Quest Diagnostics Inc (DGX) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Microchip Technology Inc. — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Microchip Technology Inc. trades at $75.55 (market cap $41.01B). The key difference: Microchip Technology Inc. is the larger of the two by market cap, and Microchip Technology Inc. pays the higher dividend (2.41%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Microchip Technology Inc. for 63 Days on average.
| DGX | MCHP | |
|---|---|---|
Market Cap | $25.48B | $41.01B |
Volume | 941,866 | 9,972,516 |
Sector | Health | Technology |
52-Week High | $247.45 | $102.97 |
52-Week Low | $173.49 | $49.02 |
Typical Hold Time | 56 Days | 63 Days |
Enterprise Value | $31.23B | $46.13B |
Dividend Yield | 1.49% | 2.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
MCHP trades at $75.52, down 3.2% over 24 hours, with technical indicators showing a bearish trend. The company reported a net loss of -$500K in 2025, though it has consistently beaten EPS estimates in recent quarters. Recent news highlights expansion in Ethernet and 48V power portfolios, including the acquisition of Hailo, targeting automotive and industrial demand. Analyst consensus is strongly bullish with a $110.50 price target, but high valuation ratios and significant debt pose risks.
The outlook is mixed: strong analyst support and strategic expansions in AI and data centers offer growth potential, but high P/E of 111.06 and net income margin pressure from 2025 raise concerns. Investors face upside from earnings beats and sector demand against valuation and cyclical semiconductor risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
